Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 801473, 14 pages
http://dx.doi.org/10.1155/2014/801473
Research Article

In Vitro Chronic Administration of ERbeta Selective Ligands and Prostate Cancer Cell Growth: Hypotheses on the Selective Role of 3beta-Adiol in AR-Positive RV1 Cells

1Department of Pharmacological and Biomolecular Sciences, University of Milano, Via Balzaretti 9, 20133 Milano, Italy
2Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, Via Vetoio, Coppito 2, 67100 L’Aquila, Italy

Received 31 January 2014; Accepted 27 March 2014; Published 29 April 2014

Academic Editor: Giovanni Luca Gravina

Copyright © 2014 Alessandra Colciago et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Alessandra Colciago, Massimiliano Ruscica, Ornella Mornati, et al., “In Vitro Chronic Administration of ERbeta Selective Ligands and Prostate Cancer Cell Growth: Hypotheses on the Selective Role of 3beta-Adiol in AR-Positive RV1 Cells,” BioMed Research International, vol. 2014, Article ID 801473, 14 pages, 2014. https://doi.org/10.1155/2014/801473.